Pay in 4 interest-free payments of $6.36 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Human fibroblasts cultured in serum-free conditions regained full viability and proliferative capacity at GHK concentrations as low as 10 M (one nanomolar) suggesting extraordinary potency for fibroblast recovery applications
Department of Tissue Engineering and Regenerative Medicine (DTERM), Faculty of Medicine, Universiti Kebangsaan Malaysia, 56000 Cheras, Kuala Lumpur, Malaysia
In the event of GLS or ASNS inhibition, compensatory mechanisms may emerge, potentially accounting for the diminished anticancer efficacy observed in GLS targeting
Referenced Citations T
& Kakizaki, H
Further development continued in the HERMIONE Phase II trial, although clinical success was constrained by tumor heterogeneity and variability in HER2 expression
US$ 21.54
US$ 29.25
US$ 20.57
US$ 22.27
US$ 21.79
US$ 21.84
US$ 21.21
US$ 28.30
